AOLS.OB Insider Trading Activity and SEC Form 4 Filings
AOLS.OB insider trading summary
No open-market insider purchases or sales of Aeolus Pharmaceuticals, Inc. (AOLS.OB) have been reported on SEC Form 4 in the past 12 months.
Latest AOLS.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 18, 2008 | Xmark Opportunity Partners, LLC | 10% Owner | Buy | $2K (6,000 @ $0.41) |
| Aug 8, 2008 | Xmark Opportunity Partners, LLC | 10% Owner | Buy | $2K (6,000 @ $0.40) |
| Aug 7, 2008 | Xmark Opportunity Partners, LLC | 10% Owner | Buy | $80 (200 @ $0.40) |
| Aug 4, 2008 | Xmark Opportunity Partners, LLC | 10% Owner | Buy | $1K (4,000 @ $0.36) |
| Aug 4, 2008 | Xmark Opportunity Partners, LLC | 10% Owner | Buy | $6K (16,100 @ $0.35) |
| Apr 29, 2008 | Xmark Opportunity Partners, LLC | 10% Owner | Buy | $9K (20,000 @ $0.46) |
| Apr 15, 2008 | Xmark Opportunity Partners, LLC | 10% Owner | Buy | $23K (50,000 @ $0.47) |
| Apr 3, 2008 | Xmark Opportunity Partners, LLC | 10% Owner | Buy | $7K (15,100 @ $0.48) |
| Mar 24, 2008 | Xmark Opportunity Partners, LLC | 10% Owner | Buy | $4K (10,000 @ $0.36) |
| Mar 20, 2008 | Xmark Opportunity Partners, LLC | 10% Owner | Buy | $8K (20,000 @ $0.38) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.